Notes

• [1]
  S.J. Reiser, “The Clinical Record in Medicine. Part 1 : Learning from Cases”, Annals of Internal Medicine, 1,14(10), 1991, p. 902-907, http://www.annals.org/content/114/10/902.extract.
• [2]
  Medical Research Council, “Streptomycin Treatment of Pulmonary Tuberculosis”, British Medical Journal, 2, 1948, p. 769-782, http://www.bmj.com/content/317/7167/1248.3.full.
• [3]
  D.L. Sackett et al., Evidence-Based Medicine : How To Practice and Teach EBM, 2^e éd., Philadelphia, Churchill Livingstone, 2000.
• [4]
  Calculs effectués sur la littérature indexée entre 1966 et aujourd’hui dans la base de données bibliographique médicale Medline, http://www.nlm.nih.gov/bsd/pmresources.html.
• [5]
  D.E. Riesenberg, “Case Reports in the Medical Literature”, Journal of the American Medical Association, 255, 15, 1986, p. 2067, http://jama.ama-assn.org/content/255/15/2067.1.extract?sid=a210daeb-e3d6-4218-9288-851e49f16c74.
• [6]
  Anonyme, “Pneumocystis Pneumonia – Los Angeles”, Morbidity and Mortality Weekly Report, 30, 21, 1981, p. 250-252, http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm ; K.B. Hymes, T. Cheung, J.B. Greene, N.S. Prose, A. Marcus, H. Ballard et al., “Kaposi’s Sarcoma in homosexual Men – A Report of Eight Cases”, The Lancet, 2, 8247, 1981, p. 598-600, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(81)92740-9/abstract.
• [7]
  Y.K. Loke et al., “Case Reports of Suspected Adverse Drugs Reactions – Systematic Literature Survey of Follow-up”, British Medical Journal, 332, 2006, p. 335-339, http://www.bmj.com/content/332/7537/335.full.
• [8]
  G. Grateau et al., « Accidents hémorragiques graves lors d’un traitement par héparine de bas poids moléculaire. A propos de deux observations », La Revue de médecine interne, 18, 5, 1997, p. 411-415, http://www.sciencedirect.com/science/article/pii/S0248866397825143.
• [9]
  P. Cestac, H. Bagheri, M. Lapeyre-Mestre, P. Sie, A. Fouladi, E. Maupas et al., “Utilisation and Safety of Low Molecular weight heparins : Prospective Observational Study in Medical Inpatients”, Drug Safety, 26, 3, 2003, p. 197-207, http://adisonline.com/drugsafety/pages/articleviewer.aspx?year=2003&issue=26030&article=00005&type=abstract.
• [10]
  J. Hirsh & R. Raschke, “Heparin and Low-Molecular-Weight Heparin : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy”, Chest, 126, 3 (Supplément), 2003, p. 188S-203S, http://chestjournal.chestpubs.org/content/126/3_suppl/188S.long.
• [11]
  J. Albrecht, A. Meves & M. Bigby, “Case Reports and Case Series from Lancet Had Significant Impact on Medical Literature”, Journal of Clinical Epidemiology, 58, 12, 2005, p. 1227-1232, http://www.jclinepi.com/article/S0895-4356(05)00188-5/abstract.
• [12]
  P.S. Hench, “Analgesia Accompanying hepatitis and Jaundice in Cases of Chronic Arthritis, Fibrositis and Sciatic Pain”, Proceedings of the Staff Meetings of the Mayo Clinic, 8, 1933, p. 430-437.
• [13]
  P. S. Hench, “The Ameliorating Effect of Pregnancy on Chronic Atrophic (Infectious, Rheumatoid) Arthritis, Fibrositis, and Intermittent Hydrarthrosis”, Proceedings of the Staff Meetings of the Mayo Clinic, 13, 1938, p. 161-167.
• [14]
  P.S. Hench, E.C. Kendall, C.H. Slocumb & H.F. Polley, “The Effect of a Hormone of the Adrenal Cortex (17-hydroxy-11-Dehydrocorticosterone : Compound E) and of Pituitary Adrenocorticotropic Hormone on Rheumatoid Arthritis”, Proceedings of the Staff Meetings of the Mayo Clinic, 24, 1949, p. 181-197.
• [15]
  I.E. Lundberg et al., “Corticosteroids – From an Idea to Clinical Use”, Best Practice & Research Clinical Rheumatology, 18, 1, 2004, p. 7-19, http://www.bprclinrheum.com/article/S1521-6942(03)00123-2/abstract.
• [16]
  M. Wani, E. Nga & R. Navaratnasingham, “Should a Patient with Primary Intracerebral Haemorrhage Receive Antiplatelet or Anticoagulant Therapy ?”, British Medical Journal, 331, 7514, 2005, p. 439-442, http://www.bmj.com/content/331/7514/439.full.
• [17]
  C. Fery-Blanco, F. Pelletier, P. Humbert, F. Aubin, « Mucinose dermique faciale associée à un cancer médullaire de la thyroïde sporadique métastatique », La Revue de médecine interne, 27, 12, 2006, p. 954-957, http://www.em-consulte.com/article/55137.
• [18]
  R.B. Haynes, “Loose Connections between Peer-Reviewed Clinical Journals and Clinical Practice”, Annals of Internal Medicine, 113, 9, 1990, p. 724-728, http://www.annals.org/content/113/9/724.abstract ; B. Haynes, P. Glasziou & S. Straus, “Advances in Evidence-Based Information Resources for Clinical Practice”, American College of Physicians Journal Club, 132, 1, 2000, p. A11-A14, http://ebm.bmj.com/content/5/1/4.extract.
• [19]
  F.G. Banting, C.H. Best, J.B. Collip, W.R. Campbell & A.A. Fletcher, “Pancreatic Extracts in the Treatment of Diabetes Mellitus : Preliminary Report”, Canadian Medical Association Journal, 12, 1922, p. 141-146. Repris dans Canadian Medical Association Journal, 145, 1991, p. 1281-1286, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1335942/pdf/cmaj00251-0099.pdf.
• [20]
  B. Riou, P. Barriot, A. Rimailho & F.-J. Baud, “Treatment of Severe Chloroquine Poisoning”, New England Journal of Medicine, 318, 1, 1988, p. 1-6, http://www.nejm.org/doi/full/10.1056/NEJM198801073180101.
• [21]
  J.W. Conn, “Part I. Painting Background. Part II. Primary Aldosteronism, a New Clinical Syndrome”, The Journal of Laboratory and Clinical Medicine, 45, 1, 1955, p. 3-17. Repris dans idem, 116, 2, 1990, p. 253-267.
• [22]
  N. Postel-Vinay, A Century of Arterial Hypertension : 1896-1996, Chichester, John Wiley & Sons, 1997.
• [23]
  C. Martyn, “Case Reports, Case Series and Systematic Reviews”, Quarterly Journal of Medicine, 95, 4, 2002, p. 197-198, http://qjmed.oxfordjournals.org/content/95/4/197.full.
• [24]
  D.J. Pierson, “Case reports in Respiratory Care”, Respiratory Care, 49, 10, 2004, p. 1186-1194, http://www.rcjournal.com/contents/10.04/10.04.1186.pdf.
• [25]
  S. Corrao, R. D’Alia, S. Caputo, S. Arnone, G.B. Pardo & T. Jefferson, “A Systematic Approach to Medical Decision-Making of uncommon Clinical Pictures : a Case of Ulcerative Skin Lesions by Palm Tree Thorn Injury and a One-Year Follow-Up”, Informatics for Health and Social Care, 30, 3, 2005, p. 203-210, http://informahealthcare.com/doi/abs/10.1080/14639230500209104?prevSearch=allfield%253A%2528Corrao%2529&searchHistoryKey=
• [26]
  R.B. Haynes, “Of Studies, Syntheses, Synopses, Summaries, and Systems : the ‘5S’ Evolution of Information Services for Evidence-Based health Care Decisions”, American College of Physicians Journal Club, 145, 3, 2006, p. A8, http://ebn.bmj.com/content/10/1/6.extract.
• [27]
  P. Glasziou, J. Vandenbroucke & I. Chalmers, “Assessing the Quality of Research”, British Medical Journal, 328, 7430, 2004, p. 9-41, http://www.bmj.com/content/328/7430/39.full.
• [28]
  D. Atkins, D. Best, P.A. Briss, M. Eccles, y. Falck-Ytter, S. Flottorp et al., “Grading Quality of Evidence and Strength of Recommendations”, British Medical Journal, 328, 7454, 2004, p. 1490, http://www.bmj.com/content/328/7454/1490.full.
• [29]
  R.B. Haynes, “Loose Connections Between Peer-Reviewed Clinical Journals and Clinical Practice”, art. cit., http://www.annals.org/content/113/9/724.abstract
• [30]
  D.L. Sackett, S.E. Straus, W.S. Richardson, W. Rosenberg, R.B. Haynes, Evidence-Based Medicine : How To Practice and Teach EBM, New-York, Churchill Livingstone, 1997.
• [31]
  P. Glasziou, I. Chalmers, M. Rawlins & P. McCulloch, “When are Randomised Trials Unnecessary ? Picking Signal from Noise”, British Medical Journal, 334, 7589, 2007, p. 349-351, http://www.bmj.com/content/334/7589/349.abstract.
• [32]
  J.K. Aronson & M. Hauben, “Anecdotes that Provide Definitive Evidence”, British Medical Journal, 333, 7581, 2006, p. 1267-1269, http://www.bmj.com/content/333/7581/1267.full.
• [33]
  D. Burch, “Anecdotally Speaking”, The Lancet, 362, 9388, 2003, p. 1004.
• [34]
  B. Trachtenberg, R. Bush & V. Ramanathan, “Abdominal Aortic Aneurysm Presenting as an Epigastric Mass”, The Lancet, 368, 9547, 2006, p. 1622, http://www.lancet.com/journals/lancet/article/PIIS0140-6736(06)69664-5/fulltext.
• [35]
  M.I. Neira, J. Sanchez, I. Moreno, A. Chiaraviglio, A. Rayo, J. Gutierrez et al., “Occam Can Be wrong : a Young Man with Lumbar Pain and Acute weakness of the Legs”, The Lancet, 367, 9509, 2006, p. 540, http://www.lancet.com/journals/lancet/article/PIIS0140-6736(06)68191-9/fulltext.
• [36]
  F. Dagognet, « Erreur », in D. Lecourt (dir.), Dictionnaire de la pensée médicale, Paris, PUF, 2004, p. 439-441.
• [37]
  Department of Clinical Epidemiology and Biostatistics McMaster University Health Science Center, “How to Read Clinical Journals : I. Why to Read Them and How to Start Reading Them Critically”, Canadian Medical Association Journal, 124, 1981, p. 555-558, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1705173/ ; D.L. Sackett, R.B. Haynes, G.H. Guyatt & P. Tugwell, Clinical Epidemiology, a Basic Science for Clinical Medicine, Boston, Little, Brown & Co Inc, 1985 (2^e éd., 1991).
• [38]
  E.A. McGlynn, S.M. Asch, J. Adams, J. Keesey, J. Hicks, A. DeCristofaro, E.A. Kerr, “The Quality of Health Care Delivered to Adults in the United States”, New England Journal of Medicine, 348, 26, 2003, p. 2635-2645, http://www.nejm.org/doi/full/10.1056/NEJMsa022615.
• [39]
  P. Glasziou & B. Haynes, “The Paths from Research to Improved Health Outcomes”, American College of Physicians Journal Club, 142, 2, 2005, p. A8-A10, http://ebn.bmj.com/content/8/2/36.extract.
• [40]
  R.S. Hayward, G.H. Guyatt, K.A. Moore, K.A. McKibbon & A.O. Carter, “Canadian Physicians’ Attitudes about and Preferences Regarding Clinical Practice Guidelines”, Canadian Medical Association Journal, 156, 12, 1997, p. 1715-1723, http://www.cmaj.ca/content/156/12/1715.reprint ; M.D. Cabana, C.S. Rand, N.R. Powe, A.W. Wu, M.H. Wilson, P.A. Abboud et al., “Why Don’t Physicians Follow Clinical Practice Guidelines ? A Framework for Improvement”, Journal of the American Medical Association, 282, 15, 1999, p. 1458-1465, http://rds.epi-ucsf.org/ticr/syllabus/courses/66/2009/10/22/Lecture/readings/Cabana.JAMA.1999.pdf ; R. Sood, A. Sood, A.K. Ghosh, “Non-Evidence-Based Variables Affecting Physicians’ Test-Ordering Tendencies : a Systematic Review”, Netherlands Journal of Medicine, 65, 5, 2007, p. 167-177, http://www.njmonline.nl/getpdf.php?t=a&id=10000176.
• [41]
  AGREE collaboration. Appraisal of Guidelines Research and Evaluation, http://www.agreecollaboration.org/ ; The Conference On Guideline Standardization. COGS statement, http://gem.med.yale.edu/cogs/.
• [42]
  M.W. Enkin & A.R. Jadad, “Using Anecdotal Information in Evidence-Based Health Care”, Annals of Oncology, 9, 1998, p. 963-966, http://annonc.oxfordjournals.org/content/9/9/963.
• [43]
  T.B. Newman, “The Power of Stories over Statistics”, British Medical Journal, 327, 7429, 2003, p. 1424-1427, http://www.bmj.com/content/327/7429/1424.full.
• [44]
  F. Godlee, “Applying Research Evidence to Individual Patients”, British Medical Journal, 316, 1998, p. 1621-1622, http://www.bmj.com/content/316/7145/1621.full.
• [45]
  C. Del Mar, “Asymptomatic Haematuria… in the Doctor”, British Medical Journal, 320, 2000, p. 165-166, http://www.bmj.com/content/320/7228/165.full?ijkey=5f1a5feb56a5092821a380a754dd3f330f951170&keytype2=tf_ipsecsha.
• [46]
  W. Windelband, “Geschichte und Naturwissenschaft”, Straßburger Rektoratsrede 1894, http://www.hs-augsburg.de/~harsch/germanica/Chronologie/19Jh/Windelband/win_rede.html. Wilhelm Windelband, « Qu’est-ce que la philosophie ? » et autres textes, traduit par E. Dufour, Paris, Vrin, 2002.
• [47]
  J.C. Wyatt, “Management of Explicit and Tacit Knowledge”, Journal of the Royal Society of Medicine, 94, 1, 2001, p. 6-9, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1280081/.
• [48]
  M.W. Enkin & A.R. Jadad, “Using Anecdotal Information in Evidence-Based Health Care”, art. cit., http://annonc.oxfordjournals.org/content/9/9/963 ; G.P. Browman, “Essence of Evidence-Based Medicine : A Case Report”, Journal of Clinical Oncology, 17, 7, 1999, p. 1969-1973, http://jco.ascopubs.org/content/17/7/1969.full.pdf.
• [49]
  Anonyme, “Patient n plus 1”, Canadian Medical Association Journal, 172, 12, 2005, p. 1525-1527, http://www.cmaj.ca/content/172/12/1527.full.
• [50]
  R.B. Haynes, P.J. Devereaux & G.H. Guyatt, “Clinical Expertise in the Era of Evidence-Based Medicine and Patient Choice”, Evidence Based Medicine, 7, 2, 2002, p. 36-38, http://ebm.bmj.com/content/7/2/36.extract ; G. Norman, “Building on Experience – the Development of Clinical Reasoning”, New England Journal of Medicine, 355, 21, 2006, p. 2251-2252, http://www.nejm.org/doi/full/10.1056/NEJMe068134.
• [51]
  G.P. Browman, “Essence of Evidence-Based Medicine : A Case Report”, art. cit., http://jco.ascopubs.org/content/17/7/1969.full.pdf ; K.M. Hunter, “A Science of Individuals : Medicine and Casuistry”, The Journal of Medicine and Philosophy, 14, 2, 1989, p. 193-212, http://jmp.oxfordjournals.org/content/14/2/193.abstract.
• [52]
  M. Marcq, P. Germaud, L. Cellerin, C. Sagan & E. Chailleux, « Aspergilloses respiratoires complexes : difficultés diagnostiques et thérapeutiques », Revue des maladies respiratoires, 21, 6, 2004, p. 1162-1166, http://www.em-consulte.com/article/144691.
• [53]
  F. Davidoff, “On Being a Patient”, Annals of Internal Medicine, 124, 2, 1996, p. 269-270.
• [54]
  K.A. Bramstedt & A.C. Arroliga, “On the Dilemma of Enigmatic Refusal of Life-Saving Therapy”, Chest, 126, 2, 2004, p. 630-633, http://chestjournal.chestpubs.org/content/126/2/630.full.
• [55]
  F. McAlister, S. Straus, G. Guyatt & R. Haynes, “Integrating Research Evidence with the Care of the Individual Patient”, Journal of the American Medical Association, 283, 21, 2000, p. 2829-2836.
• [56]
  J. McCormick, “Death of the Personnal Doctor”, The Lancet, 348, 1996, p. 667-668, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(96)03512-X/fulltext.
• [57]
  R.B. Haynes, P.J. Devereaux & G.H. Guyatt, “Clinical Expertise in the Era of Evidence-Based Medicine and Patient Choice”, art. cit., http://ebm.bmj.com/content/7/2/36.extract
• [58]
  J. Faust & O. Schreiner, “A Swallowed Toothbrush”, The Lancet, 357, 9261, 2001, p. 1012, http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)04238-0/fulltext.
• [59]
  R. Charon, “Narrative and Medicine”, New England Journal of Medicine, 350, 9, 2004, p. 862-864, http://coe.stanford.edu/courses/ethmedreadings10/NarrativeMedicine.pdf ; J.F. Steiner, “The Use of Stories in Clinical Research and Health Policy”, Journal of the American Medical Association, 294, 22, 2005, p. 2901-2904, http://jama.ama-assn.org/content/294/22/2901.extract.
• [60]
  T. Greenhalgh, “Narrative Based Medicine : Narrative Based Medicine in an Evidence Based World”, British Medical Journal, 318, 7179, 1999, p. 323-325, http://www.bmj.com/content/318/7179/323.1.full.
• [61]
  S. Straus, B. Haynes, P. Glasziou, K. Dickersin, G. Guyatt, “Misunderstandings, Misperceptions, and Mistakes”, American College of Physicians Journal Club, 146, 2, 2007, p. A11, http://ebm.bmj.com/content/12/1/2.2.extract.
• [62]
  A.M. Bayoumi & P.A. Kopplin, “The Storied Case Report”, Canadian Medical Association Journal, 171, 6, 2004, p. 569-570, http://www.cmaj.ca/content/171/6/569.full.pdf.
• [63]
  Remerciements. Pour leurs nombreuses remarques et suggestions, toute ma gratitude va aux Professeurs Loïc Capron, Gilles Grateau, Joël Ménard et Jean Mosconi, aux Docteurs Laurent Bonnardot, Isabelle Colombet, Christel Daniel-Le Bozec, Pierre Durieux, Hervé Mentec, Brigitte Ranque et Renaud Snanoudj, et enfin à Julie Nies.